companydata.dkBioMed Invest ApS: Financial statements 2021
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 246 and a net result of DKK 7,319,836 compared with DKK 5,871 the year before. That is a decrease of 99.1% compared with the year before. Equity amounted to DKK 8,629,393. The solvency ratio was 99.5%. The company had 1 employee in the financial year.
- Gross Profit
- 246 kr.
- Profit/Loss
- 7,319,836 kr.
- Equity
- 8,629,393 kr.
- Total Assets
- 8,676,504 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 246 | 7.3 mio. | 8.6 mio. | 1 |
| 2020 | - | 28 t. | 6 t. | 1.4 mio. | - |
| 2019 | - | -16 t. | 17 t. | 1.5 mio. | - |
| 2018 | - | -35 t. | -16 t. | 1.5 mio. | - |
| 2017 | - | 137 t. | -183 t. | 1.6 mio. | - |
Find more companies like BioMed Invest ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BioMed Invest ApS has published its annual report for 2020. Gross profit came to DKK 27,606, and the net result was DKK 5,871.
As of June 28, 2021, EY Godkendt Revisionspartnerselskab has stepped down as auditor of BioMed Invest ApS.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.